Serum markers of periodontal disease status and inflammation in hemodialysis patients

American Journal of Kidney Diseases

Volumn 40, Issue 5, 2002, Pages 983-989

  Rahmati, Margaret A ^a,b,c   Craig, Ronald G ^a,b,c   Homel, Peter ^a,b,c   Kaysen, George A ^a,b,c   Levin, Nathan W ^a,b,c  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

^c RENAL RESEARCH INSTITUTE   (United States)

Author keywords

Acute phase; Albumin; C Reactive protein (CRP); Iron; Porphyromonas gingivalis

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN G; IRON; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN; TRIACYLGLYCEROL;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; ASSAY; CAMPYLOBACTER; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; IRON BLOOD LEVEL; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; SERUM; SPECIES; STATISTICAL ANALYSIS; TANNERELLA FORSYTHENSIS;

EID: 0036840213     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2002.36330     Document Type: Article

References (44)

1. US Renal Data System: USRDS 1998 Annual Data Report. Patient mortality and survival. Am J Kidney Dis 32:S69-S80, 1998 (suppl 1)
2. Yeun JY, Levine RA, Mantadilok V, Kaysen GA: C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35:469-476, 2000
3. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843, 2000
4. Tataru MC, Heinrich J, Junker R, et al: C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris. Eur Heart J 21:1000-1008, 2000
5. Strandberg TE, Tilvis RS: C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol 20:1057-1060, 2000
6. Rohde LE, Hennekens CH, Ridker PM: Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol 84:1018-1022, 1999
7. Morrow DA, Ridker PM: C-reactive protein, inflammation, and coronary risk. Med Clin North Am 84:149-161, 2000
8. Lagrand WK, Visser CA, Hermens WT, et al: C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon? Circulation 100:96-102, 1999
9. Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS: Acute phase inflammatory response to periodontal disease in the US population. J Dent Res 78:1777-1782, 2000
10. Fredriksson MI, Figueredo CMS, Custafsson A, Bergstrom KG, Asman BE: Effect of periodontitis and smoking on blood leukocytes and acute-phase proteins. J Periodontol 70:1355-1360, 1999
11. Loos BG, Cranandijk J, Hoek FJ, Wertheim-van Dillen PME, Van der Velden U: Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 71:1528-1534, 2000
12. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon J, De Nardin E: Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 72:1221-1227, 2001
13. DeStefano F, Anda RF, Dahn HS, Williamson DF, Russell CM: Dental disease and risk of coronary heart disease and mortality. BMJ 306:688-691, 1989
14. Joshipura KJ, Rimm EB, Douglass CW, Trichopulos D, Ascherio A, Willett WC: Poor oral health and coronary heart disease. J Dent Res 75:1631-1636, 1996
15. Arbes SJ, Slade GD, Beck JD: Association between extent of periodontal attachment loss and self-reported history of heart attack: An analysis of the NHANES III data. J Dent Res 78:1777-1782, 1999
16. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S: Periodontal disease and cardiovascular disease. J Periodontol 67:1123-1137, 1996
17. Haffajee AD, Socransky SS: Microbial etiological agents of destructive periodontal diseases. Periodontology 2000 5:78-111, 1994
18. Dzink JL, Scoransky SS, Haffajee AD: The predominant microflora of active and inactive lesions of destructive periodontitis. J Clin Periodontol 15:316-323, 1988
19. Moore WE, Moore LH, Ranney RR, Smibert RM, Burmeister JA, Schenkein HA: The microflora of periodontal sites showing active disease progression. J Clin Periodontol 18:729-739, 1991
20. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL: Microbial complexes in dental plaque. J Clin Periodontol 25:134-144, 1998
21. Taubman MA, Haffajee AD, Socransky SS, Smith DJ, Ebersole JL: Longitudinal monitoring of humoral antibody in subjects with destructive periodontal diseases. J Periodont Res 27:511-521, 1992
22. Craig RG, Boylan R, Yip J, et al: Serum IgG antibody response to periodontal pathogens in minority populations: Relationship to periodontal disease progression. J Periodont Res 37:132-146, 2002
23. Ebersole JL, Frey DE, Taubman MA, Smith DJ: An ELISA for measuring serum antibodies to Actinobacillus actinomycetemcomitans. J Periodont Res 15:621-632, 1982
24. Mouton C, Hammond PG, Slots J, Genco RJ: Serum antibodies to oral Bacteroides asaccharolyticus (Bacteroides gingivalis). Infect Immun 31:182-192, 1981
25. Ebersole JL, Taubman MA, Smith DJ, Frey DE: Human immune responses to oral microorganisms: Patterns of systemic antibody levels to Bacteroides species. Infect Immun 51:507-513, 1986
26. Gunsolley JC, Tew JG, Gooss C, Marshall DR, Burmeister JA, Schenkein HA: Serum antibodies to periodontal bacteria. J Periodontol 61:412-419, 1990
27. Califano JV, Gunsolley JC, Schenkein HA, Tew JG: A comparison of IgG antibody reactive with Bacteroides forsythus and Porphyromonas gingivalis in adult and earlyonset periodontitis. J Periodontol 68:734-738, 1997
28. Papapanou PN, Neiderud AM, Papadimitriou A, Sandros J, Dahlen G: "Checkerboard" assessments of periodontal microbiota and serum antibody responses: A case control study. J Periodontol 71:885-897, 2000
29. Brown LJ, Löe H: Prevalence, extent, severity and progression of periodontal disease. Periodontology 2000 2:57-71, 1993
30. Naugle K, Darby ML, Bauman DB, Lineberger LT, Powers R: The oral health status of individuals on renal dialysis. Ann Periodontol 3:197-205, 1998
31. Klassen JT, Krasko BM: The dental health status of dialysis patients. J Can Dent Assoc 68:34-38, 2002
32. Albers FJ: Clinical considerations in hemodialysis access infection. Adv Ren Replace Ther 3:208-217, 1996
33. Lonnemann G: The quality of dialysate: An integrated approach. Kidney Int Suppl 76:S112-S119, 2000
34. Ebersole JL, Sandoval MN, Steffen MJ, Cappelli D: Serum antibody in Actinobacillus actinomycetemcomitans-infected patients with periodontal disease. Infect Immun 59:1795-1802, 1991
35. Colombo AP, Sakellari D, Haffajee AD, Tanner A, Cugini MA, Socransky SS: Serum antibodies reacting with subgingival species in refractory periodontitis subjects. J Clin Periodontol 25:596-604, 1998
36. Cohen G, Haag-Weber M, Horl WH: Immune dysfunction in uremia. Kidney Int Suppl 62:S79-S82, 1997
37. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E: Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation 100:230-235, 1999
38. Jialal I, Stein D, Balis D, Grundy SM, Adams-Huet B, Devaraj S: Effect of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation 103:1933-1935, 2001
39. Stenvinkel P, Andersson P, Wang T, et al: Do ACE-inhibitors suppress tumour necrosis factor-alpha production in advanced chronic renal failure? J Intern Med 246:503-507, 1999
40. Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P: Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 100:793-798, 1999
41. Gierens H, Nauck M, Roth M, et al: Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements. Arterioscler Thromb Vasc Biol 20:1777-1783, 2000
42. Glassock RJ: What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients? Semin Dial 13:167-169, 2000
43. Degoulet P, Legrain M, Reach I, et al: Mortality risk factors in patients treated by chronic hemodialysis. Nephron 31:103-110, 1982
44. US Department of Health and Human Services: Oral Health in America: A Report of the Surgeon General-Executive Summary. Bethesda, MD, National Institute of Dental and Craniofacial Research, The National Institutes of Health, 2000